Neuronetics Company Leadership
STIM Stock | USD 2.53 0.08 3.07% |
Neuronetics' insiders are aggressively selling. The analysis of insiders' sentiment of trading Neuronetics stock suggests that most insiders are panicking at this time. Neuronetics employs about 203 people. The company is managed by 10 executives with a total tenure of roughly 474 years, averaging almost 47.0 years of service per executive, having 20.3 employees per reported executive.
Neuronetics' Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-02-28 | William Andrew Macan | Disposed 22377 @ 3.16 | View | ||
2024-02-27 | Stephen Furlong | Disposed 21272 @ 3.33 | View | ||
2024-02-26 | Keith J Sullivan | Disposed 20292 @ 3.3 | View | ||
2024-02-22 | Keith J Sullivan | Disposed 20851 @ 3.23 | View | ||
2024-02-20 | Keith J Sullivan | Disposed 23958 @ 2.96 | View | ||
2024-02-14 | William Andrew Macan | Disposed 15621 @ 3.38 | View | ||
2024-02-09 | Stephen Furlong | Disposed 14710 @ 3.51 | View | ||
2024-02-06 | Stephen Furlong | Disposed 5813 @ 3.39 | View | ||
2024-01-10 | Keith J Sullivan | Disposed 10013 @ 3.01 | View | ||
2023-12-21 | William Andrew Macan | Disposed 11663 @ 2.52 | View | ||
2023-12-19 | William Andrew Macan | Disposed 11664 @ 2.24 | View | ||
2023-10-06 | William Andrew Macan | Disposed 1469 @ 1.16 | View | ||
2023-07-21 | Keith J Sullivan | Disposed 6551 @ 2.04 | View | ||
2023-07-19 | Keith J Sullivan | Disposed 6479 @ 2.07 | View | ||
2023-07-11 | William Andrew Macan | Disposed 2645 @ 2.13 | View |
Monitoring Neuronetics' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Neuronetics |
Neuronetics' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Neuronetics' future performance. Based on our forecasts, it is anticipated that Neuronetics will maintain a workforce of about 200 employees by June 2024.Neuronetics Management Team Effectiveness
The company has return on total asset (ROA) of (0.1537) % which means that it has lost $0.1537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7248) %, meaning that it created substantial loss on money invested by shareholders. Neuronetics' management efficiency ratios could be used to measure how well Neuronetics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of May 2024, Return On Tangible Assets is likely to drop to -0.28. In addition to that, Return On Capital Employed is likely to drop to -0.33. At this time, Neuronetics' Net Tangible Assets are very stable compared to the past year. As of the 20th of May 2024, Other Current Assets is likely to grow to about 7.6 M, while Non Current Assets Total are likely to drop about 13.4 M.As of the 20th of May 2024, Common Stock Shares Outstanding is likely to drop to about 17.5 M. In addition to that, Net Loss is likely to drop to about (35.1 M)
Neuronetics Workforce Comparison
Neuronetics is rated fourth in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 2,258. Neuronetics holds roughly 203 in number of employees claiming about 9% of equities under Health Care industry.
Neuronetics Profit Margins
The company has Profit Margin (PM) of (0.38) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.39) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.39.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.84 | 0.6966 |
|
|
Neuronetics Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neuronetics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neuronetics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Neuronetics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.3571 | 5 | 14 | 520,000 | 200,569 |
2023-09-01 | 0.5 | 2 | 4 | 57,000 | 22,185 |
2023-06-01 | 3.5 | 7 | 2 | 263,639 | 300,996 |
2023-03-01 | 0.2917 | 7 | 24 | 677,019 | 468,531 |
2022-12-01 | 0.1 | 1 | 10 | 100,000 | 320,968 |
2022-03-01 | 0.6 | 6 | 10 | 709,872 | 60,755 |
2021-12-01 | 2.0 | 4 | 2 | 42,797 | 15,594 |
2021-09-01 | 0.5 | 2 | 4 | 25,616 | 60,140 |
2021-06-01 | 1.0 | 7 | 7 | 45,940 | 61,159 |
2021-03-01 | 1.25 | 10 | 8 | 495,427 | 112,293 |
2020-06-01 | 1.75 | 7 | 4 | 182,500 | 30,996 |
2020-03-01 | 5.0 | 20 | 4 | 874,523 | 22,635 |
2019-09-01 | 1.5 | 6 | 4 | 220,430 | 59,213 |
2019-06-01 | 1.5833 | 19 | 12 | 150,134 | 138,961 |
2019-03-01 | 3.5 | 14 | 4 | 298,177 | 52,476 |
2018-09-01 | 1.4762 | 31 | 21 | 6,336,316 | 6,223,355 |
Neuronetics Notable Stakeholders
A Neuronetics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Neuronetics often face trade-offs trying to please all of them. Neuronetics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Neuronetics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Keith Sullivan | CEO President | Profile | |
Rusty Page | Senior Quality | Profile | |
Lisa MetznerRosas | Senior Officer | Profile | |
Andrew Macan | Gen VP | Profile | |
Claire Sears | VP Marketing | Profile | |
Rick Grubbs | Senior Accounts | Profile | |
Cory Anderson | Senior Clinical | Profile | |
Kara Thornton | VP Director | Profile | |
Stephen MS | CFO VP | Profile | |
Sara Grubbs | Senior Officer | Profile |
About Neuronetics Management Performance
The success or failure of an entity such as Neuronetics often depends on how effective the management is. Neuronetics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Neuronetics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Neuronetics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.27) | (0.28) | |
Return On Capital Employed | (0.32) | (0.33) | |
Return On Assets | (0.26) | (0.27) | |
Return On Equity | (0.88) | (0.93) |
The data published in Neuronetics' official financial statements usually reflect Neuronetics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Neuronetics. For example, before you start analyzing numbers published by Neuronetics accountants, it's critical to develop an understanding of what Neuronetics' liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Neuronetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Neuronetics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Neuronetics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Neuronetics. Please utilize our Beneish M Score to check the likelihood of Neuronetics' management manipulating its earnings.
Neuronetics Workforce Analysis
Traditionally, organizations such as Neuronetics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Neuronetics within its industry.Neuronetics Manpower Efficiency
Return on Neuronetics Manpower
Revenue Per Employee | 351.5K | |
Revenue Per Executive | 7.1M | |
Net Loss Per Employee | 148.7K | |
Net Loss Per Executive | 3M | |
Working Capital Per Employee | 364.4K | |
Working Capital Per Executive | 7.4M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Neuronetics Stock analysis
When running Neuronetics' price analysis, check to measure Neuronetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuronetics is operating at the current time. Most of Neuronetics' value examination focuses on studying past and present price action to predict the probability of Neuronetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuronetics' price. Additionally, you may evaluate how the addition of Neuronetics to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Neuronetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 2.523 | Quarterly Revenue Growth 0.121 | Return On Assets (0.15) | Return On Equity (0.72) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.